US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.8726

-0.0174-1.96%

Post-market: 0.90680.0342+3.92%19:21 EDT

Volume:317.18K

Turnover:283.18K

Market Cap:40.79M

PE:-0.97

High:0.9179

Open:0.8900

Low:0.8684

Close:0.8900

Loading ...

Overview Company News Filings

BRIEF-Reviva Announces Preliminary Topline Data For The Long-Term Open Label Extension Portion Of The Phase 3 Recover Study Evaluating Brilaroxazine In Schizophrenia

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 Recover Study Evaluating Brilaroxazine in Schizophrenia

THOMSON REUTERS

Reviva Pharmaceuticals- Full Data Set From Open-Label Extension (Ole) of Recover Expected in Q1 2025

THOMSON REUTERS

Reviva Pharmaceuticals- All Three Doses of Brilaroxazine (15 Mg, 30 Mg and 50 Mg) Tested Efficacious & Generally Well-Tolerated

THOMSON REUTERS

Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

RVPH: Year-End OLE Update

Zacks Small Cap Research

Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter - Earnings Summary

Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate

BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.25

Reviva Pharmaceuticals Q3 EPS USD -0.25

THOMSON REUTERS

Reviva Pharmaceuticals Q3 Net Income USD -8.4 Million

THOMSON REUTERS

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Maxim Group Keeps Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)

BRIEF-Reviva Announces Enrollment Update For Open Label Extension Study Evaluating Brilaroxazine In Schizophrenia

Reviva Pharmaceuticals Holdings- Brilaroxazine Generally Well Tolerated in Patients With Acute and Stable Schizophrenia

THOMSON REUTERS

Reviva Pharmaceuticals Holdings, Inc. - Topline Data From 1-Year Ole Trial Expected December 2024

THOMSON REUTERS

Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

Calendar of U.S. Earnings Expected in the Week Ahead

Reviva Pharmaceuticals Holdings, Inc. expected to post a loss of 25 cents a share - Earnings Preview

Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RVPH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RVPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPH\",,,,,undefined,":{"symbol":"RVPH","market":"US","secType":"STK","nameCN":"Reviva Pharmaceuticals Holdings, Inc.","latestPrice":0.8726,"timestamp":1746129600000,"preClose":0.89,"halted":0,"volume":317180,"hourTrading":{"tag":"盘后","latestPrice":0.9068,"preClose":0.8726,"latestTime":"19:21 EDT","volume":418,"amount":370.7289,"timestamp":1746141690668},"delay":0,"floatShares":40777960,"shares":46739949,"eps":-0.902598,"marketStatus":"Not Yet Opened","change":-0.0174,"latestTime":"05-01 16:00:00 EDT","open":0.89,"high":0.91785,"low":0.8684,"amount":283179.445848,"amplitude":0.055562,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.902598,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746172800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.89,"preHourTrading":{"tag":"盘前","latestPrice":0.8942,"preClose":0.89,"latestTime":"09:28 EDT","volume":433,"amount":369.7080003,"timestamp":1746106138771},"postHourTrading":{"tag":"盘后","latestPrice":0.9068,"preClose":0.8726,"latestTime":"19:21 EDT","volume":418,"amount":370.7289,"timestamp":1746141690668},"volumeRatio":0.714684,"impliedVol":0.3493,"impliedVolPercentile":0.432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RVPH\",,,,,undefined,":{"symbol":"RVPH","floatShares":40777960,"roa":"-98.20%","roe":"-916.17%","lyrEps":-0.902598,"volumeRatio":0.714684,"shares":46739949,"dividePrice":0,"high":0.91785,"amplitude":0.055562,"preClose":0.89,"low":0.8684,"week52Low":0.485,"pbRate":"50.19","week52High":4.28,"institutionHeld":0,"latestPrice":0.8726,"eps":-0.902598,"divideRate":0,"volume":317180,"delay":0,"ttmEps":-0.902598,"open":0.89,"prevYearClose":1.81,"prevWeekClose":0.8552,"prevMonthClose":0.89,"prevQuarterClose":0.9538,"fiveDayClose":0.9,"twentyDayClose":0.5617,"sixtyDayClose":2.02},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RVPH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2491696184","title":"BRIEF-Reviva Announces Preliminary Topline Data For The Long-Term Open Label Extension Portion Of The Phase 3 Recover Study Evaluating Brilaroxazine In Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2491696184","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491696184?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:37","pubTimestamp":1734356276,"startTime":"0","endTime":"0","summary":"Dec 16  - Reviva Pharmaceuticals Holdings, Inc. :   * REVIVA ANNOUNCES POSITIVE PRELIMINARY TOPLINE DATA FOR THE LONG-TERM OPEN LABEL EXTENSION PORTION OF THE PHASE 3 RECOVER STUDY EVALUATING BRILAROXAZINE IN SCHIZOPHRENIA   * FULL DATA SET FROM OPEN-LABEL EXTENSION  OF RECOVER EXPECTED IN Q1 2025   * ALL THREE DOSES OF BRILAROXAZINE  TESTED EFFICACIOUS & GENERALLY WELL-TOLERATEDSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2491971693","title":"Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 Recover Study Evaluating Brilaroxazine in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2491971693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491971693?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA3VRBTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2491693199","title":"Reviva Pharmaceuticals- Full Data Set From Open-Label Extension (Ole) of Recover Expected in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693199","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693199?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA3VRBTW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2491160693","title":"Reviva Pharmaceuticals- All Three Doses of Brilaroxazine (15 Mg, 30 Mg and 50 Mg) Tested Efficacious & Generally Well-Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2491160693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491160693?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA3VRBTW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2491693246","title":"Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2491693246","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491693246?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354000,"startTime":"0","endTime":"0","summary":"– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year – – Generally well-tolerated with low rates of adverse events and discontinu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997485/0/en/Reviva-Announces-Positive-Preliminary-Topline-Data-for-the-Long-Term-Open-Label-Extension-Portion-of-the-Phase-3-RECOVER-Study-Evaluating-Brilaroxazine-in-Schizophrenia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADHD","BK4085","BK4135","TRAE","RVPH","CNS","BK4007","DDI"],"gpt_icon":0},{"id":"2484928291","title":"RVPH: Year-End OLE Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2484928291","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484928291?lang=en_us&edition=fundamental","pubTime":"2024-11-19 17:25","pubTimestamp":1732008300,"startTime":"0","endTime":"0","summary":"On November 14th, 2024, Reviva Pharmaceutical Holdings, Inc.  reported third quarter 2024 financial and operational results and filed its Form 10-Q with the SEC. Reviva provided updates on its open label extension  trial and provided guidance for further milestones for the OLE and targeted initiation of the RECOVER-2 study for 1Q:25, depending on the availability of financing. We see a capital raise or a strategic partnership as a possibility in the near term to support further development. The preparation work for RECOVER-2 has been completed and we anticipate a rapid enrollment once started. Below, we summarize the operational and financial achievements for the third quarter and for 2024.Poster at American Society for Clinical Pharmacology & Therapeutics  Meeting – March 2024. Poster at Schizophrenia International Research Society  Meeting – April 2024. Presentations at American Society for Pharmacology and Experimental Therapeutics – May 2024. General & administrative expenses total","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DYxAgeRW54zkJNngpBQveg--~B/aD0xMjg0O3c9MTM2NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/scr.zacks.com/416b7ca43f6341d3f351f7657566bc92","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DYxAgeRW54zkJNngpBQveg--~B/aD0xMjg0O3c9MTM2NjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/scr.zacks.com/416b7ca43f6341d3f351f7657566bc92"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rvph-end-ole-092500373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RVPHW","ABBV","BK4007","RVPH"],"gpt_icon":1},{"id":"2483794623","title":"Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter  - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483794623","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483794623?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:01","pubTimestamp":1731679291,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc. reports results for the quarter  - Earnings SummaryReviva Pharmaceuticals Holdings, Inc. RVPH.OQ reported a quarterly adjusted loss of 25 cents per share for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL8N3MM12Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH"],"gpt_icon":1},{"id":"2483335912","title":"Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483335912","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483335912?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:35","pubTimestamp":1731623740,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 47.92 percent increase over losses of $(0.48) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41994284/reviva-pharmaceuticals-q3-2024-gaap-eps-0-25-beats-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.25) Beats $(0.26) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH"],"gpt_icon":0},{"id":"2483356028","title":"BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2483356028","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483356028?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:25","pubTimestamp":1731623145,"startTime":"0","endTime":"0","summary":"BRIEF-Reviva Pharmaceuticals Q3 EPS USD -0.25\n\n\nNov 14 (Reuters) - Reviva Pharmaceuticals Q3 net income USD -8.4 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLX7537CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH"],"gpt_icon":0},{"id":"2483235609","title":"Reviva Pharmaceuticals Q3 EPS USD -0.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2483235609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483235609?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:25","pubTimestamp":1731623100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLX7537CF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2483560993","title":"Reviva Pharmaceuticals Q3 Net Income USD -8.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2483560993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483560993?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:25","pubTimestamp":1731623100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nPLX7537CF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2483359861","title":"Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2483359861","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483359861?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:25","pubTimestamp":1731623100,"startTime":"0","endTime":"0","summary":"– 108 patients have completed 1-year of treatment in 1-year open-label extension  trial –。– Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine’s improvement on negative symptoms and other key symptom domains of schizophrenia –。– Topline data from OLE trial expected in December 2024 –。CUPERTINO, Calif., Nov. 14, 2024  -- Reviva Pharmaceuticals Holdings, Inc.  , a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system , inflammatory and cardiometabolic diseases, today reported financial results for the third quarter ended September 30, 2024 and summarized recent business highlights.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7k3ezddlH91gmDtxJmd5Dw--~B/aD0xNjY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e572996f485da9c2266397515ab947f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7k3ezddlH91gmDtxJmd5Dw--~B/aD0xNjY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e572996f485da9c2266397515ab947f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reviva-reports-third-quarter-2024-222500171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RVPHW","BK4085","BK4135","CNS","DDI","ADHD","BK4007","RVPH"],"gpt_icon":1},{"id":"2483523968","title":"Maxim Group Keeps Their Hold Rating on Reviva Pharmaceuticals Holdings (RVPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483523968","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483523968?lang=en_us&edition=fundamental","pubTime":"2024-11-14 04:15","pubTimestamp":1731528934,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Jason McCarthy maintained a Hold rating on Reviva Pharmaceuticals Holdings (RVPH – Research Report) yesterday. The company’s sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-reviva-pharmaceuticals-holdings-rvph?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-reviva-pharmaceuticals-holdings-rvph?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVPH"],"gpt_icon":0},{"id":"2482043077","title":"BRIEF-Reviva Announces Enrollment Update For Open Label Extension Study Evaluating Brilaroxazine In Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2482043077","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482043077?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:22","pubTimestamp":1731417728,"startTime":"0","endTime":"0","summary":"Nov 12  - Reviva Pharmaceuticals Holdings, Inc. :   * REVIVA ANNOUNCES ENROLLMENT UPDATE FOR OPEN LABEL EXTENSION STUDY EVALUATING BRILAROXAZINE IN SCHIZOPHRENIA   * REVIVA PHARMACEUTICALS HOLDINGS- BRILAROXAZINE GENERALLY WELL TOLERATED IN PATIENTS WITH ACUTE AND STABLE SCHIZOPHRENIA   * REVIVA PHARMACEUTICALS HOLDINGS, INC. - TOPLINE DATA FROM 1-YEAR OLE TRIAL EXPECTED DECEMBER 2024Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH"],"gpt_icon":1},{"id":"2482702726","title":"Reviva Pharmaceuticals Holdings- Brilaroxazine Generally Well Tolerated in Patients With Acute and Stable Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702726","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482702726?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:00","pubTimestamp":1731416403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA28BML8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RVPH"],"gpt_icon":0},{"id":"2482020857","title":"Reviva Pharmaceuticals Holdings, Inc. - Topline Data From 1-Year Ole Trial Expected December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2482020857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482020857?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:00","pubTimestamp":1731416403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA28BML8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVPH","BK4007"],"gpt_icon":0},{"id":"2482770154","title":"Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2482770154","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482770154?lang=en_us&edition=fundamental","pubTime":"2024-11-12 21:00","pubTimestamp":1731416400,"startTime":"0","endTime":"0","summary":"– 108 patients have completed 1-year of treatment –。–Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia –。– Topline data from 1-year open-label extension  trial now expected in December 2024 –。“We are pleased with the pace of enrollment of our OLE study which includes 108 patients that have completed 12 months of treatment and over 250 patients have completed 6 months of treatment. Importantly, we have collected long-term safety data in 100 patients with one year of treatment which is a requirement for our planned New Drug Application  submission to the Food and Drug Administration ,” said Laxminarayan Bhat, Ph.D., Founder, President, and CEO ofReviva. “Brilaroxazine continues to be generally well tolerated across patients with acute and stable schizophrenia in the OLE study to date. We now expect to report topline 12-month long-term safety and efficacy data in December of 2024.”Long-term safety data from 100 patients who have completed 12","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7k3ezddlH91gmDtxJmd5Dw--~B/aD0xNjY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e572996f485da9c2266397515ab947f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7k3ezddlH91gmDtxJmd5Dw--~B/aD0xNjY7dz0zNjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e572996f485da9c2266397515ab947f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reviva-announces-enrollment-open-label-130000974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RVPHW","DDI","BK4085","CNS","RVPH","BK4135","BK4007","ADHD"],"gpt_icon":1},{"id":"2482420129","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2482420129","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482420129?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:00","pubTimestamp":1731322800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Angi Inc Class A                                3Q       .00       AMC. ·Global Ship Lease                                3Q      2.41   8:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","DDI","DAVA","CYTH","INTS","XP","DAVE","CCLD","ARMK","ABOS","OBIO","ATER","FTCI","GATO","ICL","BLFS","TWKS","DHT","CRVO","FIHL","ASRT","AMTX","AZN","GAUZ","AXSM","IKT","CNTA","GENI","CHGG","EQ","IAC","NRGV","LAZR","FBRX","CAE","TSVT","ABSI","CNNE","KEP","NOTE","XGN","MLYS","ATAI","AVTE","CLRB","DHX","RVPH","FLNG","EARN","CRDL"],"gpt_icon":0},{"id":"2482148517","title":"Reviva Pharmaceuticals Holdings, Inc.    expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148517","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482148517?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:02","pubTimestamp":1731081748,"startTime":"0","endTime":"0","summary":"* Reviva Pharmaceuticals Holdings, Inc.     is expected to show no change in quarterly revenue when it reports  results on November 12 (estimated) for the period ending January 1 0001   *    * LSEG's ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Reviva Pharmaceuticals Holdings, Inc.    expected to post a loss of 25 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVPH"],"gpt_icon":0},{"id":"2481606218","title":"Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481606218","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481606218?lang=en_us&edition=fundamental","pubTime":"2024-11-06 21:00","pubTimestamp":1730898000,"startTime":"0","endTime":"0","summary":"CUPERTINO, Calif., Nov.  06, 2024  (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/06/2975650/0/en/Reviva-to-Present-Positive-Speech-Latency-Data-for-Brilaroxazine-in-Schizophrenia-From-the-Phase-3-RECOVER-Trial-at-the-CNS-Summit-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4135","CNS","BK4007","SMMF","RVPH"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":60,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RVPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"RVPH","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2024-11-14","symbol":"RVPH","fiscalQuarterEnding":"2024/09","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2024-08-14","symbol":"RVPH","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2024-05-14","symbol":"RVPH","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-04-15","symbol":"RVPH","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1713153600000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RVPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RVPH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":6,"updateTime":1736568000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RVPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RVPH","date":"2025-04-30","current":-1.370073,"percent":0.818352,"low":-43.457351,"twenty":-10.181944,"median":-3.789718,"eighty":-1.537845,"high":-0.516004,"avg":-6.763989,"sd":8.504812,"marketCap":40990935},"quantilePoints":[{"date":"2020-12-18","current":-31.330659,"twenty":-43.335769,"median":-40.129759,"eighty":-38.250742,"marketCap":73115357},{"date":"2020-12-24","current":-34.020665,"twenty":-41.400005,"median":-35.603022,"eighty":-32.889281,"marketCap":79392938},{"date":"2020-12-31","current":-34.59427,"twenty":-40.070161,"median":-34.811843,"eighty":-33.703957,"marketCap":80731540},{"date":"2021-01-08","current":-37.106261,"twenty":-38.830962,"median":-35.444787,"eighty":-33.901989,"marketCap":86593693},{"date":"2021-01-15","current":-37.185378,"twenty":-37.153731,"median":-36.354641,"eighty":-34.250107,"marketCap":86778327},{"date":"2021-01-22","current":-35.207433,"twenty":-37.169555,"median":-36.354641,"eighty":-34.637785,"marketCap":82162459},{"date":"2021-01-29","current":-32.121837,"twenty":-37.074614,"median":-35.444787,"eighty":-33.86243,"marketCap":74961704},{"date":"2021-02-05","current":-37.383173,"twenty":-37.098349,"median":-35.286551,"eighty":-33.664319,"marketCap":87239914},{"date":"2021-02-12","current":-35.998611,"twenty":-37.042966,"median":-35.662361,"eighty":-33.822871,"marketCap":84008806},{"date":"2021-02-19","current":-34.21846,"twenty":-36.948025,"median":-35.444787,"eighty":-33.822871,"marketCap":79854525},{"date":"2021-02-26","current":-36.433759,"twenty":-36.810755,"median":-35.286551,"eighty":-33.427281,"marketCap":85024297},{"date":"2021-03-05","current":-30.974629,"twenty":-36.789789,"median":-35.207433,"eighty":-33.229487,"marketCap":72284500},{"date":"2021-03-12","current":-33.545958,"twenty":-36.749835,"median":-35.088756,"eighty":-33.090635,"marketCap":78285129},{"date":"2021-03-19","current":-30.143892,"twenty":-36.671112,"median":-34.811843,"eighty":-32.39875,"marketCap":70345835},{"date":"2021-03-26","current":-14.396421,"twenty":-36.591995,"median":-34.59427,"eighty":-31.647131,"marketCap":54467248},{"date":"2021-04-01","current":-13.6644,"twenty":-36.591995,"median":-34.21846,"eighty":-31.552189,"marketCap":51697727},{"date":"2021-04-09","current":-12.249158,"twenty":-36.512877,"median":-33.921768,"eighty":-30.808482,"marketCap":46343319},{"date":"2021-04-16","current":-10.760715,"twenty":-36.477274,"median":-33.624681,"eighty":-14.894196,"marketCap":40711960},{"date":"2021-04-23","current":-10.541108,"twenty":-36.441671,"median":-33.437171,"eighty":-13.762003,"marketCap":39881103},{"date":"2021-04-30","current":-14.079212,"twenty":-36.370465,"median":-33.229487,"eighty":-13.962089,"marketCap":53267122},{"date":"2021-05-07","current":-13.273989,"twenty":-36.101464,"median":-32.82381,"eighty":-13.625359,"marketCap":50220649},{"date":"2021-05-14","current":-11.785545,"twenty":-36.006523,"median":-32.39875,"eighty":-13.254468,"marketCap":44589289},{"date":"2021-05-21","current":-12.560104,"twenty":-35.998611,"median":-32.032829,"eighty":-12.556477,"marketCap":50036014},{"date":"2021-05-28","current":-21.627663,"twenty":-35.777081,"median":-31.647131,"eighty":-12.424844,"marketCap":86158685},{"date":"2021-06-04","current":-21.454642,"twenty":-35.650493,"median":-31.568013,"eighty":-12.512686,"marketCap":85469415},{"date":"2021-06-11","current":-20.892323,"twenty":-35.413139,"median":-31.350439,"eighty":-12.552849,"marketCap":83229289},{"date":"2021-06-18","current":-21.19511,"twenty":-35.23908,"median":-30.143892,"eighty":-12.593143,"marketCap":84435511},{"date":"2021-06-25","current":-21.584408,"twenty":-35.207433,"median":-22.233238,"eighty":-12.717652,"marketCap":85986367},{"date":"2021-07-02","current":-19.724429,"twenty":-35.207433,"median":-21.584408,"eighty":-12.831206,"marketCap":78576720},{"date":"2021-07-09","current":-19.767684,"twenty":-35.191609,"median":-21.541153,"eighty":-12.987371,"marketCap":78749038},{"date":"2021-07-16","current":-17.085854,"twenty":-35.136226,"median":-21.433014,"eighty":-13.215427,"marketCap":68065361},{"date":"2021-07-23","current":-16.56679,"twenty":-35.057109,"median":-21.228621,"eighty":-13.273989,"marketCap":65997552},{"date":"2021-07-30","current":-15.139364,"twenty":-34.93052,"median":-21.19511,"eighty":-13.283749,"marketCap":60311079},{"date":"2021-08-06","current":-14.793322,"twenty":-34.811843,"median":-21.022089,"eighty":-13.366711,"marketCap":58932540},{"date":"2021-08-13","current":-15.139364,"twenty":-34.732725,"median":-20.957206,"eighty":-13.547276,"marketCap":60311079},{"date":"2021-08-20","current":-9.404797,"twenty":-34.606137,"median":-20.719301,"eighty":-13.215427,"marketCap":44585323},{"date":"2021-08-27","current":-10.139106,"twenty":-34.560566,"median":-20.546281,"eighty":-12.58213,"marketCap":48066459},{"date":"2021-09-03","current":-12.229061,"twenty":-34.393389,"median":-19.940706,"eighty":-12.320198,"marketCap":57974309},{"date":"2021-09-10","current":-12.53973,"twenty":-34.178901,"median":-19.767684,"eighty":-12.23308,"marketCap":59447097},{"date":"2021-09-17","current":-12.624458,"twenty":-34.020665,"median":-19.443269,"eighty":-12.042659,"marketCap":59848767},{"date":"2021-09-24","current":-12.483245,"twenty":-33.981106,"median":-18.253748,"eighty":-11.971352,"marketCap":59179318},{"date":"2021-10-01","current":-11.946634,"twenty":-33.822871,"median":-17.79523,"eighty":-11.901446,"marketCap":56635410},{"date":"2021-10-08","current":-11.155841,"twenty":-33.783233,"median":-17.202503,"eighty":-11.778852,"marketCap":52886494},{"date":"2021-10-15","current":-10.590988,"twenty":-33.608936,"median":-16.501907,"eighty":-11.723903,"marketCap":50208697},{"date":"2021-10-22","current":-9.941407,"twenty":-33.526179,"median":-16.047726,"eighty":-11.517346,"marketCap":47129230},{"date":"2021-10-29","current":-10.254066,"twenty":-33.443105,"median":-15.64687,"eighty":-11.410024,"marketCap":48611451},{"date":"2021-11-05","current":-11.132986,"twenty":-33.427281,"median":-15.204247,"eighty":-11.214727,"marketCap":52778146},{"date":"2021-11-12","current":-11.074391,"twenty":-33.387722,"median":-15.139364,"eighty":-11.178215,"marketCap":52500367},{"date":"2021-11-19","current":-7.451852,"twenty":-33.229487,"median":-15.006439,"eighty":-11.137557,"marketCap":47399949},{"date":"2021-11-26","current":-8.309145,"twenty":-33.229487,"median":-14.793322,"eighty":-11.074391,"marketCap":52853041},{"date":"2021-12-03","current":-8.02338,"twenty":-33.090635,"median":-14.685184,"eighty":-10.760715,"marketCap":51035343},{"date":"2021-12-10","current":-8.243199,"twenty":-32.556985,"median":-14.53379,"eighty":-10.590988,"marketCap":52433572},{"date":"2021-12-17","current":-6.352759,"twenty":-32.517427,"median":-14.37202,"eighty":-10.488445,"marketCap":40408806},{"date":"2021-12-23","current":-6.418704,"twenty":-32.422485,"median":-14.152414,"eighty":-10.293745,"marketCap":40828275},{"date":"2021-12-31","current":-6.352759,"twenty":-32.272161,"median":-13.786404,"eighty":-10.250209,"marketCap":40408806},{"date":"2022-01-07","current":-6.528614,"twenty":-32.145572,"median":-13.383792,"eighty":-10.126941,"marketCap":41527389},{"date":"2022-01-14","current":-4.462318,"twenty":-31.979425,"median":-13.273989,"eighty":-9.941407,"marketCap":28384040},{"date":"2022-01-21","current":-3.802862,"twenty":-31.765807,"median":-12.861361,"eighty":-9.883869,"marketCap":24189354},{"date":"2022-01-28","current":-3.901786,"twenty":-31.647131,"median":-12.619813,"eighty":-9.483877,"marketCap":24818589},{"date":"2022-02-04","current":-4.282448,"twenty":-31.623395,"median":-12.560104,"eighty":-9.291827,"marketCap":27239914},{"date":"2022-02-11","current":-4.068326,"twenty":-31.583836,"median":-12.511488,"eighty":-8.282767,"marketCap":25877919},{"date":"2022-02-18","current":-4.401405,"twenty":-31.520542,"median":-12.426759,"eighty":-8.095921,"marketCap":27996579},{"date":"2022-02-25","current":-4.686901,"twenty":-31.441424,"median":-12.257304,"eighty":-7.997002,"marketCap":29812573},{"date":"2022-03-04","current":-4.520362,"twenty":-31.354394,"median":-12.179078,"eighty":-7.807958,"marketCap":28753243},{"date":"2022-03-11","current":-4.044534,"twenty":-31.188247,"median":-12.087848,"eighty":-7.482627,"marketCap":25726586},{"date":"2022-03-18","current":-3.08992,"twenty":-30.642334,"median":-11.993856,"eighty":-7.350736,"marketCap":26331917},{"date":"2022-03-25","current":-3.782489,"twenty":-29.938186,"median":-11.946634,"eighty":-6.537407,"marketCap":32233899},{"date":"2022-04-01","current":-4.368508,"twenty":-26.895998,"median":-11.819543,"eighty":-6.392326,"marketCap":37227883},{"date":"2022-04-08","current":-4.119894,"twenty":-22.345702,"median":-11.777179,"eighty":-6.234057,"marketCap":35109223},{"date":"2022-04-14","current":-3.871279,"twenty":-21.662268,"median":-11.748936,"eighty":-6.053806,"marketCap":32990563},{"date":"2022-04-22","current":-3.711456,"twenty":-21.619012,"median":-11.706572,"eighty":-4.920297,"marketCap":31628567},{"date":"2022-04-29","current":-3.711456,"twenty":-21.584408,"median":-11.607723,"eighty":-4.648835,"marketCap":31628567},{"date":"2022-05-06","current":-3.320776,"twenty":-21.575757,"median":-11.482848,"eighty":-4.548911,"marketCap":28299244},{"date":"2022-05-13","current":-2.654845,"twenty":-21.523851,"median":-11.410024,"eighty":-4.389294,"marketCap":22624262},{"date":"2022-05-20","current":-1.772927,"twenty":-21.454642,"median":-11.340186,"eighty":-4.351364,"marketCap":26483250},{"date":"2022-05-27","current":-1.732403,"twenty":-21.445991,"median":-11.224329,"eighty":-4.287206,"marketCap":25877919},{"date":"2022-06-03","current":-1.843844,"twenty":-21.411387,"median":-11.169687,"eighty":-4.244201,"marketCap":27542580},{"date":"2022-06-10","current":-1.519652,"twenty":-21.411387,"median":-11.155841,"eighty":-4.187282,"marketCap":22699929},{"date":"2022-06-17","current":-1.215722,"twenty":-21.228621,"median":-11.127598,"eighty":-4.1397,"marketCap":18159943},{"date":"2022-06-24","current":-1.165066,"twenty":-21.201812,"median":-11.074391,"eighty":-4.13259,"marketCap":17403278},{"date":"2022-07-01","current":-1.215722,"twenty":-21.19511,"median":-10.990862,"eighty":-4.115908,"marketCap":18159943},{"date":"2022-07-08","current":-1.154935,"twenty":-21.19511,"median":-10.745051,"eighty":-4.067654,"marketCap":17251946},{"date":"2022-07-15","current":-1.023232,"twenty":-21.169157,"median":-10.693526,"eighty":-4.011226,"marketCap":15284618},{"date":"2022-07-22","current":-0.993852,"twenty":-21.073995,"median":-10.523684,"eighty":-3.889583,"marketCap":14845753},{"date":"2022-07-29","current":-0.644231,"twenty":-21.022089,"median":-10.488445,"eighty":-3.819392,"marketCap":9623256},{"date":"2022-08-05","current":-0.653349,"twenty":-21.022089,"median":-10.363475,"eighty":-3.775385,"marketCap":9759456},{"date":"2022-08-12","current":-0.719302,"twenty":-20.944229,"median":-10.280319,"eighty":-3.704353,"marketCap":10744633},{"date":"2022-08-19","current":-0.723588,"twenty":-20.840416,"median":-10.247409,"eighty":-3.647527,"marketCap":13509298},{"date":"2022-08-26","current":-1.486026,"twenty":-20.753905,"median":-10.166174,"eighty":-3.384705,"marketCap":27743927},{"date":"2022-09-02","current":-2.583548,"twenty":-20.719301,"median":-10.016887,"eighty":-3.228434,"marketCap":48234540},{"date":"2022-09-09","current":-2.376075,"twenty":-20.684697,"median":-9.948449,"eighty":-3.125436,"marketCap":44361030},{"date":"2022-09-16","current":-2.573168,"twenty":-20.563583,"median":-9.884922,"eighty":-2.6655,"marketCap":48040746},{"date":"2022-09-23","current":-1.981887,"twenty":-20.407863,"median":-9.855363,"eighty":-2.563314,"marketCap":37001596},{"date":"2022-09-30","current":-1.740995,"twenty":-20.174284,"median":-9.517768,"eighty":-2.418502,"marketCap":32504164},{"date":"2022-10-07","current":-2.551269,"twenty":-19.923404,"median":-9.390676,"eighty":-2.402354,"marketCap":47631889},{"date":"2022-10-14","current":-3.876177,"twenty":-19.845544,"median":-9.291827,"eighty":-2.408924,"marketCap":72367763},{"date":"2022-10-21","current":-3.668134,"twenty":-19.750382,"median":-8.309145,"eighty":-2.418502,"marketCap":68483617},{"date":"2022-10-28","current":-4.160868,"twenty":-19.655221,"median":-8.199235,"eighty":-2.434865,"marketCap":77682909},{"date":"2022-11-04","current":-5.507675,"twenty":-19.464897,"median":-8.094822,"eighty":-2.452564,"marketCap":102827641},{"date":"2022-11-11","current":-5.639071,"twenty":-19.179412,"median":-8.02338,"eighty":-2.496521,"marketCap":105280785},{"date":"2022-11-18","current":-4.785688,"twenty":-18.668999,"median":-7.957435,"eighty":-2.53813,"marketCap":95263778},{"date":"2022-11-25","current":-4.087347,"twenty":-18.167237,"median":-7.825544,"eighty":-2.552364,"marketCap":81362626},{"date":"2022-12-02","current":-3.717638,"twenty":-17.81946,"median":-7.561761,"eighty":-2.560029,"marketCap":74003193},{"date":"2022-12-09","current":-3.676559,"twenty":-17.805605,"median":-7.462843,"eighty":-2.575244,"marketCap":73185478},{"date":"2022-12-16","current":-3.851144,"twenty":-17.695754,"median":-7.363925,"eighty":-2.588928,"marketCap":76660766},{"date":"2022-12-23","current":-3.337658,"twenty":-17.334112,"median":-6.594559,"eighty":-2.619329,"marketCap":66439330},{"date":"2022-12-30","current":-4.36463,"twenty":-17.202503,"median":-6.539605,"eighty":-2.654845,"marketCap":86882201},{"date":"2023-01-06","current":-4.035999,"twenty":-17.109184,"median":-6.517623,"eighty":-2.676155,"marketCap":80340483},{"date":"2023-01-13","current":-4.508406,"twenty":-16.670603,"median":-6.374741,"eighty":-2.96274,"marketCap":89744203},{"date":"2023-01-20","current":-4.539215,"twenty":-16.48893,"median":-6.352759,"eighty":-3.045864,"marketCap":90357489},{"date":"2023-01-27","current":-4.477597,"twenty":-16.307258,"median":-6.25384,"eighty":-3.054404,"marketCap":89130917},{"date":"2023-02-03","current":-4.950004,"twenty":-16.116934,"median":-6.088976,"eighty":-3.075714,"marketCap":98534638},{"date":"2023-02-10","current":-4.826767,"twenty":-15.943913,"median":-5.957085,"eighty":-3.143195,"marketCap":96081493},{"date":"2023-02-17","current":-4.878116,"twenty":-15.770892,"median":-5.639071,"eighty":-3.189366,"marketCap":97103637},{"date":"2023-02-24","current":-4.785688,"twenty":-15.657833,"median":-5.584323,"eighty":-3.196469,"marketCap":95263778},{"date":"2023-03-03","current":-4.693261,"twenty":-15.584001,"median":-5.156154,"eighty":-3.217779,"marketCap":93423920},{"date":"2023-03-10","current":-4.528945,"twenty":-15.42485,"median":-4.950004,"eighty":-3.26395,"marketCap":90153061},{"date":"2023-03-17","current":-4.056538,"twenty":-15.195596,"median":-4.90379,"eighty":-3.289788,"marketCap":80749340},{"date":"2023-03-24","current":-4.035999,"twenty":-15.165317,"median":-4.853441,"eighty":-3.299155,"marketCap":80340483},{"date":"2023-03-31","current":-3.520825,"twenty":-15.139364,"median":-4.826767,"eighty":-3.310121,"marketCap":85694386},{"date":"2023-04-06","current":-3.76451,"twenty":-15.113411,"median":-4.821632,"eighty":-3.32236,"marketCap":91625502},{"date":"2023-04-14","current":-3.924165,"twenty":-15.008966,"median":-4.795958,"eighty":-3.330487,"marketCap":95511405},{"date":"2023-04-21","current":-4.57119,"twenty":-14.989769,"median":-4.785688,"eighty":-3.337658,"marketCap":111259538},{"date":"2023-04-28","current":-5.756003,"twenty":-14.897135,"median":-4.795958,"eighty":-3.338685,"marketCap":140097028},{"date":"2023-05-05","current":-7.050053,"twenty":-14.782264,"median":-4.816497,"eighty":-3.359699,"marketCap":171593295},{"date":"2023-05-12","current":-6.655115,"twenty":-14.731787,"median":-4.826767,"eighty":-3.427325,"marketCap":161980798},{"date":"2023-05-19","current":-6.549376,"twenty":-14.69816,"median":-4.852068,"eighty":-3.434428,"marketCap":154413513},{"date":"2023-05-26","current":-4.892449,"twenty":-14.646254,"median":-4.888385,"eighty":-3.474439,"marketCap":115348431},{"date":"2023-06-02","current":-5.645134,"twenty":-14.577045,"median":-4.888385,"eighty":-3.520825,"marketCap":133094343},{"date":"2023-06-09","current":-6.257784,"twenty":-14.53379,"median":-4.934219,"eighty":-3.520825,"marketCap":147538691},{"date":"2023-06-16","current":-5.443834,"twenty":-14.445223,"median":-5.001352,"eighty":-3.520825,"marketCap":128348344},{"date":"2023-06-23","current":-5.524027,"twenty":-14.406181,"median":-5.124589,"eighty":-3.524795,"marketCap":130239029},{"date":"2023-06-30","current":-5.524027,"twenty":-14.36714,"median":-5.233783,"eighty":-3.529985,"marketCap":130239029},{"date":"2023-07-07","current":-5.197389,"twenty":-14.323219,"median":-5.28192,"eighty":-3.540999,"marketCap":122537939},{"date":"2023-07-14","current":-4.803502,"twenty":-14.196335,"median":-5.18772,"eighty":-3.580071,"marketCap":113251330},{"date":"2023-07-21","current":-4.678611,"twenty":-14.079212,"median":-5.101319,"eighty":-3.604907,"marketCap":110306795},{"date":"2023-07-28","current":-4.015727,"twenty":-14.02065,"median":-4.950004,"eighty":-3.645797,"marketCap":94678111},{"date":"2023-08-04","current":-4.126208,"twenty":-13.830325,"median":-4.9334,"eighty":-3.664235,"marketCap":97282892},{"date":"2023-08-11","current":-4.150226,"twenty":-13.688801,"median":-4.888385,"eighty":-3.667765,"marketCap":97849149},{"date":"2023-08-18","current":-2.967962,"twenty":-13.508235,"median":-4.852068,"eighty":-3.598698,"marketCap":91054069},{"date":"2023-08-25","current":-3.673038,"twenty":-13.33255,"median":-4.826767,"eighty":-3.531384,"marketCap":112685073},{"date":"2023-09-01","current":-2.886749,"twenty":-13.278869,"median":-4.821632,"eighty":-3.520825,"marketCap":88562540},{"date":"2023-09-08","current":-3.004877,"twenty":-13.273989,"median":-4.815686,"eighty":-3.427325,"marketCap":92186582},{"date":"2023-09-15","current":-4.355964,"twenty":-13.215427,"median":-4.795958,"eighty":-3.427325,"marketCap":133636569},{"date":"2023-09-22","current":-3.787474,"twenty":-12.987371,"median":-4.785688,"eighty":-3.448635,"marketCap":116195864},{"date":"2023-09-29","current":-3.72841,"twenty":-12.816129,"median":-4.775418,"eighty":-3.46714,"marketCap":114383843},{"date":"2023-10-06","current":-3.824389,"twenty":-12.689064,"median":-4.767717,"eighty":-3.487725,"marketCap":117328377},{"date":"2023-10-13","current":-3.602899,"twenty":-12.6226,"median":-4.726646,"eighty":-3.503795,"marketCap":110533298},{"date":"2023-10-20","current":-2.73909,"twenty":-12.615169,"median":-4.7193,"eighty":-3.427325,"marketCap":84032486},{"date":"2023-10-27","current":-2.798153,"twenty":-12.59629,"median":-4.7138,"eighty":-3.382057,"marketCap":85844508},{"date":"2023-11-03","current":-3.632431,"twenty":-12.564825,"median":-4.693261,"eighty":-3.346427,"marketCap":111439308},{"date":"2023-11-10","current":-4.090177,"twenty":-12.552849,"median":-4.686901,"eighty":-3.382057,"marketCap":125482473},{"date":"2023-11-17","current":-2.751979,"twenty":-12.541072,"median":-4.667587,"eighty":-3.346427,"marketCap":103624966},{"date":"2023-11-24","current":-3.451837,"twenty":-12.528433,"median":-4.652892,"eighty":-3.338685,"marketCap":129977902},{"date":"2023-12-01","current":-2.89924,"twenty":-12.480349,"median":-4.639318,"eighty":-3.328901,"marketCap":109170036},{"date":"2023-12-08","current":-3.032474,"twenty":-12.460364,"median":-4.606559,"eighty":-3.300761,"marketCap":114186910},{"date":"2023-12-15","current":-2.817457,"twenty":-12.404165,"median":-4.591736,"eighty":-3.207124,"marketCap":106090528},{"date":"2023-12-22","current":-2.854529,"twenty":-12.302492,"median":-4.569567,"eighty":-3.172537,"marketCap":107486456},{"date":"2023-12-29","current":-3.714595,"twenty":-12.268601,"median":-4.55372,"eighty":-3.177168,"marketCap":139871985},{"date":"2024-01-05","current":-4.08902,"twenty":-12.254046,"median":-4.549485,"eighty":-3.181984,"marketCap":153970858},{"date":"2024-01-12","current":-2.987988,"twenty":-12.241119,"median":-4.539215,"eighty":-3.174081,"marketCap":112511796},{"date":"2024-01-19","current":-3.017645,"twenty":-12.209068,"median":-4.528945,"eighty":-3.093399,"marketCap":113628539},{"date":"2024-01-26","current":-2.884187,"twenty":-12.123827,"median":-4.508406,"eighty":-3.078707,"marketCap":108603198},{"date":"2024-02-02","current":-2.824872,"twenty":-12.099773,"median":-4.477597,"eighty":-3.054835,"marketCap":106369713},{"date":"2024-02-09","current":-3.210418,"twenty":-12.087848,"median":-4.464787,"eighty":-3.050221,"marketCap":120887364},{"date":"2024-02-16","current":-3.180761,"twenty":-12.076551,"median":-4.457057,"eighty":-3.054404,"marketCap":119770622},{"date":"2024-02-23","current":-3.210418,"twenty":-12.031362,"median":-4.446787,"eighty":-3.054404,"marketCap":120887364},{"date":"2024-03-01","current":-2.824872,"twenty":-11.95635,"median":-4.446787,"eighty":-3.049175,"marketCap":106369713},{"date":"2024-03-08","current":-2.7878,"twenty":-11.946634,"median":-4.419222,"eighty":-3.032474,"marketCap":104973785},{"date":"2024-03-15","current":-2.14275,"twenty":-11.946634,"median":-4.398422,"eighty":-3.004877,"marketCap":80684638},{"date":"2024-03-22","current":-2.046364,"twenty":-11.890149,"median":-4.385169,"eighty":-2.980573,"marketCap":77055225},{"date":"2024-03-28","current":-2.891601,"twenty":-11.844961,"median":-4.368508,"eighty":-2.973159,"marketCap":108882384},{"date":"2024-04-05","current":-2.683999,"twenty":-11.81107,"median":-4.36463,"eighty":-2.965561,"marketCap":101065187},{"date":"2024-04-12","current":-2.810043,"twenty":-11.78952,"median":-4.353822,"eighty":-2.935079,"marketCap":105811342},{"date":"2024-04-19","current":-2.147536,"twenty":-11.778852,"median":-4.333407,"eighty":-2.904992,"marketCap":84314051},{"date":"2024-04-26","current":-2.119092,"twenty":-11.754585,"median":-4.306239,"eighty":-2.886237,"marketCap":83197308},{"date":"2024-05-03","current":-2.261312,"twenty":-11.748936,"median":-4.297739,"eighty":-2.869358,"marketCap":88781020},{"date":"2024-05-10","current":-1.521764,"twenty":-11.739182,"median":-4.282472,"eighty":-2.842666,"marketCap":59745718},{"date":"2024-05-17","current":-1.198229,"twenty":-11.723903,"median":-4.27219,"eighty":-2.830803,"marketCap":47740737},{"date":"2024-05-24","current":-1.016042,"twenty":-11.698099,"median":-4.259415,"eighty":-2.817457,"marketCap":40481912},{"date":"2024-05-31","current":-1.025273,"twenty":-11.65856,"median":-4.251663,"eighty":-2.814491,"marketCap":40849692},{"date":"2024-06-07","current":-1.077659,"twenty":-11.61902,"median":-4.239637,"eighty":-2.800839,"marketCap":42936903},{"date":"2024-06-14","current":-1.122561,"twenty":-11.593612,"median":-4.234865,"eighty":-2.758636,"marketCap":44725941},{"date":"2024-06-21","current":-1.010305,"twenty":-11.556907,"median":-4.225988,"eighty":-2.728485,"marketCap":40253346},{"date":"2024-06-28","current":-0.957919,"twenty":-11.52583,"median":-4.215719,"eighty":-2.718105,"marketCap":38166136},{"date":"2024-07-05","current":-0.80076,"twenty":-11.485229,"median":-4.19562,"eighty":-2.686965,"marketCap":31904504},{"date":"2024-07-12","current":-0.950435,"twenty":-11.46014,"median":-4.169505,"eighty":-2.654543,"marketCap":37867963},{"date":"2024-07-15","current":-0.927984,"twenty":-11.454739,"median":-4.166498,"eighty":-2.64841,"marketCap":36973444},{"date":"2024-08-02","current":-0.80076,"twenty":-11.449337,"median":-4.163491,"eighty":-2.636406,"marketCap":31904504},{"date":"2024-08-09","current":-0.636268,"twenty":-11.416806,"median":-4.160051,"eighty":-2.581472,"marketCap":25350663},{"date":"2024-08-16","current":-0.579352,"twenty":-11.410024,"median":-4.148966,"eighty":-2.546889,"marketCap":20427828},{"date":"2024-08-23","current":-0.745459,"twenty":-11.366066,"median":-4.141171,"eighty":-2.47201,"marketCap":26832582},{"date":"2024-08-30","current":-0.974564,"twenty":-11.331252,"median":-4.138696,"eighty":-2.408924,"marketCap":35079169},{"date":"2024-09-06","current":-1.167638,"twenty":-11.280223,"median":-4.13259,"eighty":-2.382644,"marketCap":42028816},{"date":"2024-09-13","current":-1.029728,"twenty":-11.234667,"median":-4.129399,"eighty":-2.332558,"marketCap":37064782},{"date":"2024-09-20","current":-1.204414,"twenty":-11.217127,"median":-4.115908,"eighty":-2.309304,"marketCap":43352558},{"date":"2024-09-27","current":-1.231996,"twenty":-11.186743,"median":-4.111897,"eighty":-2.269846,"marketCap":44345365},{"date":"2024-10-04","current":-1.121668,"twenty":-11.161379,"median":-4.090177,"eighty":-2.199453,"marketCap":40374138},{"date":"2024-10-11","current":-1.066504,"twenty":-11.155841,"median":-4.085862,"eighty":-2.17598,"marketCap":38388524},{"date":"2024-10-18","current":-1.189195,"twenty":-11.155841,"median":-4.076051,"eighty":-2.147536,"marketCap":42804734},{"date":"2024-10-25","current":-1.059126,"twenty":-11.142128,"median":-4.066808,"eighty":-2.126715,"marketCap":38122966},{"date":"2024-10-31","current":-1.073062,"twenty":-11.130831,"median":-4.066632,"eighty":-2.09666,"marketCap":38624584},{"date":"2024-11-08","current":-0.874151,"twenty":-11.107728,"median":-4.056538,"eighty":-2.021735,"marketCap":31464824},{"date":"2024-11-15","current":-1.12416,"twenty":-11.076511,"median":-4.052316,"eighty":-1.959848,"marketCap":40463850},{"date":"2024-11-22","current":-1.22432,"twenty":-11.074391,"median":-4.045879,"eighty":-1.864022,"marketCap":41467086},{"date":"2024-11-29","current":-1.256023,"twenty":-11.070277,"median":-4.041806,"eighty":-1.815477,"marketCap":41467086},{"date":"2024-12-06","current":-1.448478,"twenty":-11.028636,"median":-4.035999,"eighty":-1.768875,"marketCap":47820914},{"date":"2024-12-13","current":-2.805794,"twenty":-10.894467,"median":-4.034941,"eighty":-1.768875,"marketCap":92632121},{"date":"2024-12-20","current":-1.519383,"twenty":-10.75445,"median":-4.01867,"eighty":-1.762894,"marketCap":50161798},{"date":"2024-12-27","current":-1.884035,"twenty":-10.729388,"median":-4.006339,"eighty":-1.762894,"marketCap":62200630},{"date":"2025-01-03","current":-2.035973,"twenty":-10.724136,"median":-3.986815,"eighty":-1.762894,"marketCap":67216809},{"date":"2025-01-10","current":-1.894164,"twenty":-10.705245,"median":-3.973562,"eighty":-1.765875,"marketCap":62535042},{"date":"2025-01-17","current":-1.803001,"twenty":-10.632003,"median":-3.938871,"eighty":-1.765875,"marketCap":59525334},{"date":"2025-01-24","current":-2.666539,"twenty":-10.571036,"median":-3.927751,"eighty":-1.769888,"marketCap":88034686},{"date":"2025-01-31","current":-2.595996,"twenty":-10.527169,"median":-3.916729,"eighty":-1.776979,"marketCap":85705726},{"date":"2025-02-07","current":-2.920495,"twenty":-10.500679,"median":-3.902492,"eighty":-1.786984,"marketCap":96418941},{"date":"2025-02-14","current":-2.539561,"twenty":-10.490762,"median":-3.898957,"eighty":-1.796924,"marketCap":83842558},{"date":"2025-02-21","current":-2.299713,"twenty":-10.481017,"median":-3.894235,"eighty":-1.803001,"marketCap":75924094},{"date":"2025-02-28","current":-2.01754,"twenty":-10.447013,"median":-3.881229,"eighty":-1.803001,"marketCap":66608254},{"date":"2025-03-07","current":-1.664823,"twenty":-10.4033,"median":-3.87145,"eighty":-1.803001,"marketCap":54963454},{"date":"2025-03-14","current":-1.467302,"twenty":-10.293745,"median":-3.861304,"eighty":-1.768875,"marketCap":48442366},{"date":"2025-03-21","current":-1.551954,"twenty":-10.280319,"median":-3.849599,"eighty":-1.754711,"marketCap":51237118},{"date":"2025-03-28","current":-1.537845,"twenty":-10.275068,"median":-3.835763,"eighty":-1.716193,"marketCap":50771326},{"date":"2025-04-04","current":-0.877287,"twenty":-10.253668,"median":-3.830508,"eighty":-1.67138,"marketCap":26247378},{"date":"2025-04-11","current":-0.905623,"twenty":-10.250209,"median":-3.821429,"eighty":-1.625319,"marketCap":27095148},{"date":"2025-04-17","current":-1.107619,"twenty":-10.242742,"median":-3.820335,"eighty":-1.620962,"marketCap":33138623},{"date":"2025-04-25","current":-1.406004,"twenty":-10.205599,"median":-3.804693,"eighty":-1.551954,"marketCap":42065954},{"date":"2025-04-30","current":-1.370073,"twenty":-10.181944,"median":-3.789718,"eighty":-1.537845,"marketCap":40990935}],"updateTime":1746159404744}}}